Effectiveness and safety of Sofosbuvir/Velpatasvir/Voxilaprevir for retreatment of chronic hepatitis C patients with a previous failure to direct-acting antivirals: a real-life study from the Navigatore Lombardia and Veneto Networks. (February 2019)

• Record Type: Journal Article
• Authors: Degasperi, E.; Spinetti, A.; Lombardi, A.; Landonio, S.; Scotton, P.; Pasulo, L.; Carlotto, A.; Giorgini, A.; Pozzoni, P.; Angeli, P.; Carrara, M.; Puoti, M.; Gatti, F.; Carolo, G.; Vinci, M.; Zoncada, A.; Bonfanti, P.; Aghemo, A.; Soria, A.; Centenaro, R.; Maggiolo, F.; Russo, F.P.; Rovere, P.; Piovesan, S.; Capra, F.; Viviani, F.; Morini, L.; Soffredini, R.; Carriero, C.; Paolucci, S.; Noventa, F.; Alberti, A.; Lampertico, P.; Fagiuoli, S.;
• Is Part Of: Digestive and liver disease. Volume 51(2019)Supplement 1
• Page Start: e15
• Publication Date: 2019-02
• Subjects: Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2018.11.063
• Languages: English
• ISSNs: 1590-8658